texas oncology more breakthroughs. more victories
  • Request an Appointment
  • Find a cancer center
  • Find a provider
  • Clinical Trials



Expert on Benefit of Dual HER-2 Directed Therapy, MA17R Trial

Publication: Targeted Oncology

Dr. Frankie Holmes, a breast medical oncologist at Texas Oncology−Houston Memorial City, discusses the evolution of neoadjuvant HER2-directed therapy. Dr. Holmes also stresses the need for treatments for HER2-postive patients who do not meet the present criteria for the regimen.

Read the full story from Targeted Oncology.

Related Physicians

Related Cancer Centers